US Patent Issued to UCB BIOPHARMA on July 28 for "Antibodies against interleukin-22" (British Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,304, issued on July 28, was assigned to UCB BIOPHARMA SRL (Brussels).

"Antibodies against interleukin-22" was invented by Joseph Michael David Rastrick (Slough, Great Britain), John Paul Silva (Slough, Great Britain), Kerry Louise Tyson (Slough, Great Britain), Peter Charles Elliott (Slough, Great Britain), Seppe Frans Roman Leysen (Slough, Great Britain) and Zainab Ahdash (Slough, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies binding to IL22 and inhibiting its interaction with one or more of its natural ligands. Specific examples of such antibodies are provided. The therapeutic uses of the ...